ArticleBiochemistry and biophysics reports2025
HDAC5, an early osimertinib-responsive gene, is a novel therapeutic target for the drug resistance in
Hanbing Lyu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it